Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
Recruiting · NCT07248371 · Observational (researchers observe without assigning treatment) · Lead sponsor: Chang Gung Memorial Hospital
View the official record on ClinicalTrials.gov →Interventions studied
No intervention
What this trial is about
This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.
Who can take part
Age range
20 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Individuals (male or female) aged 20 years or older
- Willing and able to provide written informed consent to participate in the study
Exclusion criteria
- Pregnant or breastfeeding women
- Patients with end-stage renal disease receiving hemodialysis or peritoneal dialysis
- Individuals currently undergoing active cancer treatment
- Recipients of any organ transplantation
- Patients diagnosed with dementia
Where it is running
3 locations listed.
- Chang Gung Memorial Hospitals, Linkou - Taoyuan, Taiwan
- Chang Gung Memorial Hospitals, Linkou - Taoyuan, Taiwan
- Chang Gung Memorial Hospitals, Linkou - Taoyuan, Taiwan